Table 2.
log NT at d0 | NT increase d0_28 | NT increase d7_28 | NT decrease d28_180 | |||||
---|---|---|---|---|---|---|---|---|
rs | p | rs | p | rs | p | rs | p | |
(A) Correlation of log TBE NT titers at d0, log TBE NT titer increase d0_d28, log TBE NT titer increase d7_d28, and log TBE NT titer decline d28_d180 with body mass index (BMI) and metabolic parameters (insulin, leptin, triglycerides, cholesterol ratio, HDL cholesterol) measured before vaccination (d0). | ||||||||
BMI | −0.20 | 0.085 | 0.017* | 0.014* | 0.019* | |||
Insulin | 0.038* | 0.011* | 0.012* | 0.024* | ||||
Leptin | −0.09 | 0.470 | 0.022* | 0.041* | −0.18 | 0.115 | ||
TG | −0.23 | 0.052 | 0.20 | 0.086 | 0.11 | 0.341 | 0.035* | |
Chol R | −0.23 | 0.050 | 0.09 | 0.408 | 0.05 | 0.638 | −0.20 | 0.079 |
HDL | 0.20 | 0.082 | −0.10 | 0.391 | 0.00 | 0.997 | 0.23 | 0.050 |
(B, C) Correlation of log TBE NT titers at d0, log TBE NT titer increase d0_d28, log TBE NT titer increase d7_d28, and log TBE NT titer decline d28_d180 with levels of testosterone, estrogen, progesterone, FSH, and LH measured before vaccination (d0) in (B) men and (C) women. | ||||||||
(B) MALES | ||||||||
Testosterone | 0.025* | −0.323 | 0.067 | −0.203 | 0.339 | 0.053 | ||
Estrogen | −0.028 | −0.066 | −0.031 | 0.115 | ||||
Progesterone | −0.094 | −0.025 | 0.194 | −0.071 | ||||
FSH | 0.057 | −0.074 | −0.016 | 0.114 | ||||
LH | 0.091 | 0.024* | −0.199 | 0.029* | ||||
(C) FEMALES | ||||||||
Testosterone | −0.257 | 0.143 | −0.125 | −0.147 | ||||
Estrogen | 0.124 | −0.194 | −0.125 | −0.021 | ||||
Progesterone | −0.255 | 0.117 | 0.048* | −0.093 | ||||
FSH | −0.036 | 0.266 | 0.286 | 0.073 | −0.026 | |||
LH | −0.116 | 0.242 | 0.033* | −0.055 |
Shown is Spearman correlation coefficient rs (+ or −) and the respective p-value;
p ≤ 0.05, rs indicated in red.